• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型叠氮化锝(III)配合物[Tc(N)(CDO)(CDOH)B-R]作为心脏成像潜在放射性示踪剂(CDOH=环己二酮二肟)。

Novel Tc(III)-azide complexes [Tc(N)(CDO)(CDOH)B-R] (CDOH=cyclohexanedione dioxime) as potential radiotracers for heart imaging.

作者信息

Liu Min, Zheng Yumin, Avcibasi Ugur, Liu Shuang

机构信息

Department of Radiation Medicine and Protection, Medical College, Soochow University, China; School of Health Sciences, Purdue University, IN, 47907, USA.

Department of Nuclear Medicine, China-Japan Friendship Hospital, Beijing, 100037, China.

出版信息

Nucl Med Biol. 2016 Nov;43(11):732-741. doi: 10.1016/j.nucmedbio.2016.05.001. Epub 2016 May 9.

DOI:10.1016/j.nucmedbio.2016.05.001
PMID:27632344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5077665/
Abstract

INTRODUCTION

In this study, novel Tc(III)-azide complexes [Tc(N)(CDO)(CDOH)B-R] (Tc-ISboroxime-N: R=IS; Tc-MPboroxime-N: R=MP; Tc-PAboroxime-N: R=PA; Tc-PYboroxime-N: R=PY; and Tc-Uboroxime-N: R=5U) were evaluated as heart imaging agents.

METHODS

Complexes [Tc(N)(CDO)(CDOH)B-R] (R=IS, MP, PA, PY and 5U) were prepared by ligand exchange between NaN and [TcCl(CDO)(CDOH)B-R]. Biodistribution and imaging studies were carried out in Sprague-Dawley rats. Image quantification was performed to compare their initial heart uptake and myocardial retention.

RESULTS

Tc-ISboroxime-N, Tc-PYboroxime-N and Tc-Uboroxime-N were prepared with high RCP (93-98%) while the RCP of Tc-MPboroxime-N and Tc-PAboroxime-N was 80-85%. The myocardial retention curves of Tc-ISboroxime-N, Tc-PYboroxime-N and Tc-Uboroxime-N were best fitted to the bi-exponential decay function. The half-time of the fast component was 1.6±0.4min for Tc-ISboroxime-N, 0.7±0.1min for Tc-PYboroxime-N and 0.9±0.4min for Tc-Uboroxime-N. The 2-min heart uptake from biodistribution studies followed the ranking order of Tc-ISboroxime-N (3.60±0.68%ID/g)>Tc-PYboroxime-N (2.35±0.37%ID/g)≫Tc-Uboroxime-N (1.29±0.06%ID/g). Tc-ISboroxime-N had the highest 2-min heart uptake among Tc radiotracers revaluated in SD rats. High quality SPECT images were obtained with the right and left ventricular walls being clearly delineated. The best image acquisition window was 0-5min for Tc-ISboroxime-N.

CONCLUSION

Both azide coligand and boronate caps had significant impact on the heart uptake and myocardial retention of complexes [Tc(N)(CDO)(CDOH)B-R]. Among the radiotracers evaluated in SD rats, Tc-ISboroxime-N has the highest initial heart uptake with the heart retention comparable to that of Tc-Teboroxime. Tc-ISboroxime-N is a promising alternative to Tc-Teboroxime for SPECT MPI.

摘要

引言

在本研究中,新型三价锝叠氮配合物[Tc(N)(CDO)(CDOH)B-R](Tc-异硫氰酸苯酯硼酸肟-N:R = IS;Tc-甲氧基苯硼酸肟-N:R = MP;Tc-对氨基苯硼酸肟-N:R = PA;Tc-吡啶硼酸肟-N:R = PY;以及Tc-尿嘧啶硼酸肟-N:R = 5U)被评估为心脏显像剂。

方法

通过NaN与[TcCl(CDO)(CDOH)B-R]之间的配体交换制备配合物[Tc(N)(CDO)(CDOH)B-R](R = IS、MP、PA、PY和5U)。在Sprague-Dawley大鼠中进行生物分布和显像研究。进行图像定量以比较它们的初始心脏摄取和心肌滞留情况。

结果

Tc-异硫氰酸苯酯硼酸肟-N、Tc-吡啶硼酸肟-N和Tc-尿嘧啶硼酸肟-N的放射性化学纯度(RCP)较高(93 - 98%),而Tc-甲氧基苯硼酸肟-N和Tc-对氨基苯硼酸肟-N的RCP为80 - 85%。Tc-异硫氰酸苯酯硼酸肟-N、Tc-吡啶硼酸肟-N和Tc-尿嘧啶硼酸肟-N的心肌滞留曲线最适合双指数衰减函数。快速成分的半衰期对于Tc-异硫氰酸苯酯硼酸肟-N为1.6±0.4分钟,对于Tc-吡啶硼酸肟-N为0.7±0.1分钟,对于Tc-尿嘧啶硼酸肟-N为0.9±0.4分钟。生物分布研究中2分钟时的心脏摄取情况按以下顺序排列:Tc-异硫氰酸苯酯硼酸肟-N(3.60±0.68%ID/g)>Tc-吡啶硼酸肟-N(2.35±0.37%ID/g)≫Tc-尿嘧啶硼酸肟-N(1.29±0.06%ID/g)。在SD大鼠中重新评估的锝放射性示踪剂中,Tc-异硫氰酸苯酯硼酸肟-N的2分钟心脏摄取量最高。获得了高质量的SPECT图像,左右心室壁清晰可辨。对于Tc-异硫氰酸苯酯硼酸肟-N,最佳图像采集窗口为0 - 5分钟。

结论

叠氮共配体和硼酸酯帽对配合物[Tc(N)(CDO)(CDOH)B-R]的心脏摄取和心肌滞留都有显著影响。在SD大鼠中评估的放射性示踪剂中,Tc-异硫氰酸苯酯硼酸肟-N具有最高的初始心脏摄取量,其心脏滞留情况与Tc-替硼酸肟相当。对于SPECT心肌灌注显像,Tc-异硫氰酸苯酯硼酸肟-N是Tc-替硼酸肟的一个有前景的替代物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/74948fbb9f4b/nihms-816368-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/1b45836ecc5d/nihms-816368-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/ee4fa98a8d42/nihms-816368-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/a32a69c7231b/nihms-816368-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/b42d372adcac/nihms-816368-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/fbdbaacb2b17/nihms-816368-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/08a736531fb8/nihms-816368-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/7bff8e65800c/nihms-816368-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/612f743297c5/nihms-816368-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/74948fbb9f4b/nihms-816368-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/1b45836ecc5d/nihms-816368-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/ee4fa98a8d42/nihms-816368-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/a32a69c7231b/nihms-816368-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/b42d372adcac/nihms-816368-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/fbdbaacb2b17/nihms-816368-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/08a736531fb8/nihms-816368-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/7bff8e65800c/nihms-816368-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/612f743297c5/nihms-816368-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d5/5077665/74948fbb9f4b/nihms-816368-f0009.jpg

相似文献

1
Novel Tc(III)-azide complexes [Tc(N)(CDO)(CDOH)B-R] (CDOH=cyclohexanedione dioxime) as potential radiotracers for heart imaging.新型叠氮化锝(III)配合物[Tc(N)(CDO)(CDOH)B-R]作为心脏成像潜在放射性示踪剂(CDOH=环己二酮二肟)。
Nucl Med Biol. 2016 Nov;43(11):732-741. doi: 10.1016/j.nucmedbio.2016.05.001. Epub 2016 May 9.
2
Impact of boronate capping groups on biological characteristics of novel (99m)Tc(III) complexes [(99m)TcCl(CDO)(CDOH)2B-R] (CDOH2 = cyclohexanedione dioxime).硼酸酯封端基团对新型(99m)Tc(III)配合物[(99m)TcCl(CDO)(CDOH)2B-R](CDOH2 = 环己二酮二肟)生物学特性的影响
Bioconjug Chem. 2015 Feb 18;26(2):316-28. doi: 10.1021/bc500583k. Epub 2015 Jan 26.
3
Novel Tc(III) Complexes [TcCl(CDO)(CDOH)B-R] (CDOH = Cyclohexanedione Dioxime) Useful as Radiotracers for Heart Imaging.新型锝(III)配合物[TcCl(CDO)(CDOH)B-R](CDOH = 环己二酮二肟)可用作心脏成像的放射性示踪剂。
Bioconjug Chem. 2016 Nov 16;27(11):2770-2779. doi: 10.1021/acs.bioconjchem.6b00552. Epub 2016 Oct 24.
4
Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime).共配体对(99m)Tc(III)配合物[(99m)Tc(L)(CDO)(CDOH)2BMe](L = Cl、F、SCN和N3;CDOH2 = 环己二酮二肟)化学和生物学性质的影响
Nucl Med Biol. 2014 Nov-Dec;41(10):813-24. doi: 10.1016/j.nucmedbio.2014.07.009. Epub 2014 Aug 1.
5
Tc-3Cboroxime: a novel Tc(iii) complex [TcCl(CDO)(CDOH)B-3C] (CDOH = cyclohexanedione dioxime; 3C-B(OH) = 3-(carbamoylphenyl)boronic acid) with high heart uptake and long myocardial retention.锝-3C硼肟:一种新型的锝(Ⅲ)配合物[TcCl(CDO)(CDOH)B-3C](CDOH = 环己二酮二肟;3C-B(OH) = 3-(氨基甲酰基苯基)硼酸),具有高心脏摄取率和长心肌滞留时间。
Dalton Trans. 2017 Oct 31;46(42):14509-14518. doi: 10.1039/c7dt01292f.
6
Sulfonyl-Containing Boronate Caps for Optimization of Biological Properties of Tc(III) Radiotracers [TcCl(CDO)(CDOH)B-R] (CDOH = Cyclohexanedione Dioxime).含磺酰基硼酸酯帽用于优化 Tc(III)放射性示踪剂 [TcCl(CDO)(CDOH)B-R](CDOH = 环己二酮二肟)的生物学性质。
J Med Chem. 2018 Jan 11;61(1):319-328. doi: 10.1021/acs.jmedchem.7b01412. Epub 2017 Dec 27.
7
Novel Approach for Tc-Labeling of Red Blood Cells: Evaluation of Tc-4SAboroxime as a Blood Pool Imaging Agent.锝标记红细胞的新方法:评估锝-4-琥珀酰亚胺硼酸肟作为血池显像剂
Bioconjug Chem. 2017 Dec 20;28(12):2998-3006. doi: 10.1021/acs.bioconjchem.7b00601. Epub 2017 Nov 30.
8
Tc-3SPboroxime: A neutral Tc(III) radiotracer with high heart uptake and long myocardial retention.锝-3SPboroxime:一种带正电荷的锝(III)放射性示踪剂,具有很高的心脏摄取率和较长的心肌滞留时间。
J Nucl Cardiol. 2021 Dec;28(6):2687-2696. doi: 10.1007/s12350-020-02087-3. Epub 2020 Mar 16.
9
A neutral technetium-99m complex for myocardial imaging.一种用于心肌显像的中性锝-99m络合物。
J Nucl Med. 1989 Nov;30(11):1830-7.
10
Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.基于共聚物的去唾液酸糖蛋白受体靶向示踪剂试剂盒用于肝脏单光子发射计算机断层显像成像。
Nucl Med Biol. 2014 Aug;41(7):587-93. doi: 10.1016/j.nucmedbio.2014.04.005. Epub 2014 Apr 12.

本文引用的文献

1
Impact of boronate capping groups on biological characteristics of novel (99m)Tc(III) complexes [(99m)TcCl(CDO)(CDOH)2B-R] (CDOH2 = cyclohexanedione dioxime).硼酸酯封端基团对新型(99m)Tc(III)配合物[(99m)TcCl(CDO)(CDOH)2B-R](CDOH2 = 环己二酮二肟)生物学特性的影响
Bioconjug Chem. 2015 Feb 18;26(2):316-28. doi: 10.1021/bc500583k. Epub 2015 Jan 26.
2
Myocardial blood flow quantification with SPECT and conventional tracers: a critical appraisal.使用单光子发射计算机断层扫描(SPECT)和传统示踪剂进行心肌血流定量:一项批判性评估。
J Nucl Cardiol. 2014 Dec;21(6):1089-91. doi: 10.1007/s12350-014-9996-z. Epub 2014 Oct 4.
3
Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime).
共配体对(99m)Tc(III)配合物[(99m)Tc(L)(CDO)(CDOH)2BMe](L = Cl、F、SCN和N3;CDOH2 = 环己二酮二肟)化学和生物学性质的影响
Nucl Med Biol. 2014 Nov-Dec;41(10):813-24. doi: 10.1016/j.nucmedbio.2014.07.009. Epub 2014 Aug 1.
4
Development of kit formulations for (99m) TcN-MPO: a cationic radiotracer for myocardial perfusion imaging.用于(99m)TcN-MPO的试剂盒配方开发:一种用于心肌灌注成像的阳离子放射性示踪剂。
J Labelled Comp Radiopharm. 2014 Jul;57(9):584-92. doi: 10.1002/jlcr.3221. Epub 2014 Jul 28.
5
Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT.使用碲锌镉单光子发射计算机断层扫描(CZT-SPECT)在心肌灌注成像中制定并验证个性化患者剂量方案。
J Nucl Cardiol. 2014 Dec;21(6):1158-67. doi: 10.1007/s12350-014-9942-0. Epub 2014 Jul 9.
6
The current and future status of nuclear cardiology: a consensus report.核素心脏病学的现状与未来:一份共识报告。
Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):949-55. doi: 10.1093/ehjci/jeu060. Epub 2014 May 12.
7
Myocardial perfusion imaging with a cadmium zinc telluride-based gamma camera versus invasive fractional flow reserve.基于碲化镉锌的γ相机心肌灌注成像与有创血流储备分数的比较
Eur J Nucl Med Mol Imaging. 2014 May;41(5):956-62. doi: 10.1007/s00259-013-2630-5. Epub 2013 Dec 6.
8
An evidence-based review of quantitative SPECT imaging and potential clinical applications.基于证据的定量 SPECT 成像及其潜在临床应用的综述。
J Nucl Med. 2013 Jan;54(1):83-9. doi: 10.2967/jnumed.112.111476.
9
Nuclear myocardial perfusion imaging with a novel cadmium-zinc-telluride detector SPECT/CT device: first validation versus invasive coronary angiography.新型碲化镉锌探测器 SPECT/CT 核心肌灌注成像:与有创冠状动脉造影的首次验证比较。
Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):2025-30. doi: 10.1007/s00259-011-1877-y. Epub 2011 Jul 15.
10
Lower dose and shorter acquisition: pushing the boundaries of myocardial perfusion SPECT.更低剂量与更短采集时间:拓展心肌灌注单光子发射计算机断层扫描的边界
J Nucl Cardiol. 2011 Oct;18(5):830-2. doi: 10.1007/s12350-011-9410-z.